Planned sale of HURN common shares via broker (NASDAQ: HURN)
Huron Consulting Group Inc. (NASDAQ: HURN) has filed a Form 144 notice indicating a proposed sale of common stock through Fidelity Brokerage Services LLC. The filing details restricted stock vesting entries of 708, 707, and 406 shares with vesting dates in October 2024, January 2025, and April 2025, respectively. This notice is a regulatory requirement for affiliates planning to sell securities and does not specify the exact timing or amounts of the executed sales, which will be reported in subsequent trade reports.
Huron Consulting Group Inc. (NASDAQ:HURN) Given Average Rating of "Moderate Buy" by Analysts
Huron Consulting Group Inc. (NASDAQ:HURN) has received a "Moderate Buy" rating from analysts, with a consensus one-year price target of $205.50. The company recently exceeded quarterly earnings expectations, reporting EPS of $1.73 and revenue of $451.77 million, and provided strong FY 2026 EPS guidance. Insider selling by directors was noted, but institutional ownership remains high, with major funds increasing their stakes.
Huron Consulting Group stock (US4474621020): insider activity and earnings keep investors alert
Huron Consulting Group has reported solid Q1 2026 earnings with continued revenue growth and profitability in its consulting business, particularly in healthcare and digital services. Despite this positive financial performance, insiders have sold a significant number of shares over the past two years, leading to questions about sentiment around the stock. The company, a Nasdaq-listed mid-cap professional services firm, is a relevant investment for US market participants interested in healthcare, higher education, and enterprise digitalization trends.
Huron Consulting Group Inc. (HURN) Hits Fresh High: Is There Still Room to Run?
Huron Consulting Group (HURN) recently reached a new 52-week high, raising questions about its future stock performance. The company's stock has surged, outperforming its sector and the broader market due to strong earnings and revenue growth, and it maintains a Zacks Rank #1 (Strong Buy). Despite the recent run-up, analysts see potential for continued growth, driven by a positive earnings outlook and favorable industry trends.
A Look At Huron Consulting Group (HURN) Valuation After Strong Q1 Growth And Reaffirmed Full Year Guidance
Huron Consulting Group (HURN) recently reported strong Q1 revenue growth and reaffirmed its full-year guidance, with revenue expected to reach up to US$1.86 billion. Despite this positive news and ongoing share buybacks, the stock has declined significantly over the past month and year, though it shows a strong 5-year return. Simply Wall St indicates the stock is currently undervalued, with a fair value of $205.50 compared to its last close of $108.13, driven by investments in digital transformation and AI-related capabilities.
Huron Consulting Group stock (US4474621020): Buyback update and record Q1 revenue
Huron Consulting Group reported record first-quarter 2026 revenue of $451.77 million and reaffirmed its full-year 2026 revenue guidance of $1.78 billion to $1.86 billion. The company also continues its share repurchase program, signaling management's confidence in its financial position and ability to return capital. For U.S. investors, the update is significant as Huron is a Nasdaq-listed professional services company deeply connected to the domestic healthcare, education, and commercial sectors, making it sensitive to broader economic trends.
Aristotle Capital Boston Sells 40,351 Huron Consulting Shares in Q1 2026 - News and Statistics
Aristotle Capital Boston sold 40,351 shares of Huron Consulting Group in Q1 2026, valued at approximately $6.07 million, reducing its stake in the company. Despite the sale and a 39% year-to-date decline in Huron's stock, the fund still holds 249,912 shares worth $31.90 million, with Huron representing 1.98% of its 13F assets. Huron Consulting Group reported strong Q1 revenue growth and reaffirmed its full-year 2026 guidance, driven significantly by its healthcare segment, suggesting potential for investors despite its recent stock performance.
Is Huron Consulting Group’s (HURN) Capital Shift Toward Buybacks Redefining Its Growth Playbook?
Huron Consulting Group (HURN) reported Q1 2026 revenues of US$451.77 million and reaffirmed its 2026 revenue guidance, alongside continued share repurchases. The company's strategy indicates a disciplined shift towards buybacks while selectively pursuing growth acquisitions, maintaining focus on organic demand in healthcare and digital projects. Despite slightly lower net income in the latest quarter, the reaffirmed guidance and capital allocation choices maintain the existing risk-reward balance, with potential margin pressure from rising costs being a key concern.
Is Huron Consulting Group’s (HURN) Capital Shift Toward Buybacks Redefining Its Growth Playbook?
Huron Consulting Group reported its Q1 2026 results, showing US$451.77 million in revenue and US$23.25 million in net income, while reaffirming its full-year 2026 revenue guidance of US$1.78 billion to US$1.86 billion. The company emphasizes a strategy of continued share repurchases alongside selective tuck-in M&A, focusing on organic demand, particularly in healthcare and digital sectors. This approach signals management's confidence in the company's valuation and its operational strengths despite potential margin pressures from rising costs and M&A integration.
Is Huron Consulting Group’s (HURN) Capital Shift Toward Buybacks Redefining Its Growth Playbook?
Huron Consulting Group (HURN) reported Q1 2026 revenue of US$451.77 million and net income of US$23.25 million, reaffirming its full-year revenue guidance of US$1.78 billion to US$1.86 billion. The company is strategically shifting its capital allocation between tuck-in M&A and share buybacks, signaling confidence in its valuation while still pursuing growth acquisitions. This move emphasizes organic growth, particularly in healthcare and digital sectors, amidst potential margin pressures from rising costs and M&A integration.
Huron Consulting Group stock (US4474621020): earnings momentum and strategy update attract investor
Huron Consulting Group reported strong Q1 2026 results with revenue growth and improved profitability, leading to an updated full-year outlook. The company specializes in consulting for healthcare, education, and corporate transformation, focusing on long-term client relationships through advisory, technology implementation, and managed services. This strategy, along with demand in its core sectors, positions Huron for continued investor attention, though its performance remains sensitive to economic conditions and staffing utilization.
Huron Consulting Group (NASDAQ:HURN) Stock Price Up 5.5% - Here's What Happened
Huron Consulting Group (NASDAQ: HURN) saw its stock price rise 5.5% on Friday, reaching a high of $107.50, despite trading volume being significantly lower than average. This surge follows the company's recent strong quarterly earnings report, where it surpassed both EPS and revenue expectations, with revenue increasing 12.1% year-over-year. Analyst sentiment remains largely positive, holding a "Moderate Buy" consensus rating with a target price of $205.50, even after a few recent downgrades.
Huron Consulting Shareholders Back Directors, Pay and Auditor
Huron Consulting Group Inc. shareholders voted to re-elect eight directors, approved executive compensation, and ratified PricewaterhouseCoopers LLP as their independent public accounting firm at their annual virtual meeting on May 8, 2026. This indicates continued investor support for the company's current governance and leadership. TipRanks' AI Analyst, Spark, rated HURN as "Neutral" due to solid business performance and reaffirmed guidance, offset by increased leverage, weaker cash flow, and a clear downtrend in technicals.
Insider Sell: Ekta Singh-bushell Sells Shares of Huron Consultin
Ekta Singh-bushell, a Director at Huron Consulting Group Inc (HURN), sold 443 shares of the company on May 11, 2026, reducing her holdings to 13,646 shares. This transaction is part of a broader trend of insider selling at Huron, with 49 insider sells and no buys over the past year. Despite the selling, the stock is considered significantly undervalued with a price-to-GF-Value ratio of 0.78, trading at $118.44 against a GF Value of $152.39.
Insider Sell Alert: Debra Zumwalt Sells Shares of Huron Consulti
Debra Zumwalt, a Director at Huron Consulting Group Inc (HURN), sold 598 shares of the company on May 11, 2026, reducing her holdings to 27,201 shares. Over the past year, she has sold a total of 1,278 shares, with no insider buys recorded, contrasting with 49 insider sells for the company. Despite the insider selling, Huron Consulting Group Inc's stock is considered significantly undervalued with a price-to-GF-Value ratio of 0.78, trading at $118.44 against a GF Value of $152.39.
Huron Consulting Group (HURN) director sells 598 shares under 10b5-1 plan
Debra Zumwalt, a director at Huron Consulting Group Inc. (HURN), sold 598 shares of common stock at $118.44 per share on May 11, 2026. This transaction was part of a pre-arranged Rule 10b5-1 trading plan adopted on May 16, 2025. Following the sale, Zumwalt directly holds 27,201 shares of HURN.
Huron (HURN) director logs small 443-share planned stock sale
Huron (HURN) director Ekta Singh-Bushell sold 443 shares of common stock on May 11, 2026, for $118.44 per share, totaling $52,469. This transaction was an automatic sale conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled rather than a discretionary decision. After the sale, Ms. Singh-Bushell directly holds 13,646 shares.
Top 10: Pharmaceutical Consulting Firms
This article lists the top 10 pharmaceutical consulting firms that are crucial for life sciences organizations navigating AI adoption, regulatory complexities, and commercial strategies in 2026. It highlights how these firms, including ZS, McKinsey, Accenture, and Deloitte, combine deep domain expertise with advanced analytics and regulatory awareness. The piece emphasizes the shift from standalone advisory services to supporting execution across various functions like clinical, commercial, and operational.
Huron Consulting Group's (NASDAQ:HURN) Conservative Accounting Might Explain Soft Earnings
Huron Consulting Group (NASDAQ:HURN) recently reported weak earnings, which the analysis attributes to a significant one-time expense of US$35m from "unusual items." The article suggests that if these non-recurring expenses are removed, the company's true earnings potential is understated, leading to an expectation of higher profits next year. Additionally, the company is experiencing strong EPS growth, indicating a potentially better outlook.
Huron (HURN) director Joy Brown granted 1,500 restricted stock units
Joy Brown, a director at Huron Consulting Group Inc. (HURN), was granted 1,500 restricted stock units (RSUs) on May 8, 2026, as part of her compensation. These RSUs will fully vest on the first anniversary of the award. Following this transaction, Brown's directly held common stock position in Huron is 10,396 shares.
Huron Earnings Story Sparks Fresh Nasdaq Index Buzz
Huron Consulting Group's recent earnings report has drawn attention to accounting quality, demand for consulting services, and enterprise modernization trends within the technology consulting sector. The company's earnings were reportedly impacted by unusual accounting-related expenses. The article also touches on the importance of accounting quality in reflecting long-term operational performance, particularly for a firm specializing in healthcare, education, and enterprise transformation consulting.
Huron Consulting (NASDAQ: HURN) holders back board, pay plan and PwC
Huron Consulting Group Inc. shareholders have approved all proposals at their May 8, 2026, Annual Meeting, including the election of all eight director nominees, the advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026. The votes demonstrated strong shareholder support for the board, the company's executive pay plan, and the chosen accounting firm. A total of 15,777,409 shares were represented at the virtual meeting.
Huron Consulting Shareholders Back Directors, Pay and Auditor
Huron Consulting shareholders approved the election of eight directors, executive compensation, and ratified PricewaterhouseCoopers LLP as their independent auditor at the May 8, 2026 annual meeting. This indicates strong investor confidence in the company's governance and leadership. Despite some concerns about increased leverage and cash flow, analysts maintain a "Buy" rating for HURN stock with a $207.00 price target.
Huron Consulting Group shareholders elect directors and approve proposals at annual meeting
Huron Consulting Group Inc. (NASDAQ:HURN) held its annual stockholders' meeting where shareholders elected eight directors to the board and approved executive compensation on an advisory basis. They also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. This comes as the company's shares are trading near their 52-week low, despite a strong performance in Q1 2026 where Huron exceeded market expectations for EPS and revenue.
Huron Consulting Group (HURN) director awarded 1,500 restricted stock units
John McCartney, a director at Huron Consulting Group (HURN), was granted 1,500 restricted stock units (RSUs) on May 8, 2026. These RSUs, which were compensation-related and had a grant price of $0.00, will vest fully on the first anniversary of the award date. Following this grant, McCartney directly holds a total of 41,817 shares of common stock.
Huron Consulting Group's (NASDAQ:HURN) Conservative Accounting Might Explain Soft Earnings
Huron Consulting Group (NASDAQ:HURN) recently posted soft earnings, which disappointed investors. However, an analysis suggests that a significant expense of US$35m attributed to unusual items likely detracted from the statutory profit. Assuming these unusual expenses are not repeated, the company's future profitability is expected to improve, indicating that current statutory profit may understate its true earnings potential.
598 HURN Shares Listed for Sale Following Vesting (HURN)
A recent Form 144 SEC filing shows that 598 shares of Huron Consulting Group Inc. (HURN) common stock are listed for sale, stemming from a restricted stock vesting event on May 9, 2026, categorized as compensation. The filing also notes a previous sale of 170 shares by Debra Zumwalt on April 2, 2026. Fidelity Brokerage Services LLC is listed as the broker of record for the planned sale of the 598 shares.
Huron Announces Fourth Quarter 2025 Financial Results and Provides 2026 Guidance
Huron Consulting Group Inc. has announced its fourth-quarter 2025 financial results and provided guidance for 2026. This information was disseminated via Quantisnow, a real-time market data platform that aggregates various financial news and SEC filings for retail investors. The article also includes recent analyst ratings and related SEC filings for HURN.
Is It Time To Revisit Huron Consulting Group (HURN) After This Year’s Share Price Slide?
Huron Consulting Group (HURN) has seen its share price decline by 27.1% year-to-date, prompting a re-evaluation of its attractiveness. Despite recent slides, the company is considered undervalued by Simply Wall St's Discounted Cash Flow (DCF) analysis and P/E ratio, suggesting a potential upside. The article encourages investors to consider different valuation narratives and revisit their theses.
How Huron’s Q1 Beat, AI Spend and Buybacks At Huron Consulting Group (HURN) Have Changed Its Investment Story
Huron Consulting Group (HURN) reported strong Q1 2026 results with revenue of US$451.77 million and reaffirmed its full-year revenue outlook, driven by record performance in its Healthcare segment, margin expansion, and increased AI investment. The company's decision to raise its share repurchase authorization to US$900 million suggests a focus on EPS accretion as part of its investment narrative. Investors are encouraged to assess whether Q1's performance and strategic investments enhance or challenge the optimistic analyst forecasts for future growth and profitability.
How Huron’s Q1 Beat, AI Spend and Buybacks At Huron Consulting Group (HURN) Have Changed Its Investment Story
Huron Consulting Group (HURN) reported strong Q1 2026 results with revenue of US$451.77 million and net income of US$23.25 million, reaffirming its full-year outlook. The company's investment story is now heavily influenced by share repurchases, continued tuck-in M&A, and increasing focus on AI capabilities, alongside its traditional strengths in healthcare and education consulting. While the earnings beat and capital allocation strategies support near-term catalysts, rising leverage and potential increases in people costs and acquisition-related spending pose risks to profitability.
Vanguard Group Inc. Sells 98,183 Shares of Huron Consulting Group Inc. $HURN
Vanguard Group Inc. has reduced its stake in Huron Consulting Group Inc. by 5.5%, selling 98,183 shares, but still holds 9.74% of the company, valued at approximately $290.4 million. Huron recently exceeded Q4 earnings and revenue expectations and provided strong FY2026 guidance. Analysts maintain a "Moderate Buy" rating with a consensus price target significantly above the current trading price.
Lisanti Capital Exits Huron Consulting With $6.8 Million Sale
Lisanti Capital Growth has fully exited its position in Huron Consulting Group (NASDAQ:HURN), selling 45,590 shares for an estimated $6.85 million. This transaction represents 1.73% of Lisanti Capital's reportable assets under management and suggests a shift in their investment thesis for the professional services firm. Despite Huron Consulting Group reporting strong Q1 earnings, the stock has experienced volatility, underperforming the S&P 500, indicating potential investor concerns about sustainability.
Huron Consulting Group (HURN) Margins Lag Bullish Narrative Despite Q1 2026 Revenue Growth
Huron Consulting Group (HURN) reported Q1 2026 revenue growth but experienced flat net income, raising concerns about margin pressure despite bullish analyst expectations. The company's valuation appears appealing with a low P/E ratio, yet its debt coverage by operating cash flow is weak, creating tension between the bullish and cautious investment narratives. Investors are urged to consider both the company's financial performance and balance sheet health when evaluating its prospects.
Lisanti Capital Exits Huron Consulting With $6.8 Million Sale
Lisanti Capital Growth has completely exited its position in Huron Consulting Group (HURN), selling 45,590 shares for an estimated $6.85 million in Q1 2026. This significant transaction represented 1.73% of the fund's assets under management and suggests HURN no longer fits Lisanti Capital's investment thesis, despite Huron Consulting's recent strong Q1 earnings report. The stock has shown volatility, underperforming the S&P 500, indicating potential concerns among investors regarding the sustainability of its growth.
Huron Consulting Group (NASDAQ:HURN) Sets New 1-Year Low - What's Next?
Huron Consulting Group (NASDAQ:HURN) recently hit a new 52-week low of $112.45, closing at $120.11, despite beating Q1 earnings and revenue estimates. While the company affirmed its full-year guidance and received some positive analyst endorsements, concerns like mixed cash flow, rising liabilities, and insider/institutional selling contributed to the stock's decline. Analysts currently have a "Moderate Buy" consensus rating with an average price target of $205.50.
Huron Consulting Earnings Call Highlights Growth And Leverage
Huron Consulting Group (HURN) reported strong Q1 2026 results with double-digit revenue growth across all segments, record performance in healthcare, and improved profitability. Despite positive indicators like strong bookings and AI-driven growth opportunities, the company faced negative free cash flow, increased leverage due to aggressive share buybacks, and temporary softness in digital revenue. Management reaffirmed full-year guidance and plans to moderate buybacks to prioritize deleveraging and maintain financial flexibility.
Huron Consulting Group Reports Strong Q1 2026 Earnings with 12% Revenue Growth
Huron Consulting Group announced strong Q1 2026 earnings, with revenues before reimbursable expenses (RBR) increasing by 12% year-over-year. This growth was primarily driven by its healthcare segment, which saw a 14% RBR increase (10% organic growth). The company affirmed its annual RBR and margin guidance, citing a strong start to the year and robust pipeline, as it continues to help clients navigate challenging markets and evolving business models, including AI strategy.
Huron Consulting Group (HURN) Margins Lag Bullish Narrative Despite Q1 2026 Revenue Growth
Huron Consulting Group (HURN) reported Q1 2026 revenue of US$451.8 million, up from Q1 2025, but net income declined slightly, indicating margin pressure despite revenue growth. The company's trailing net profit margin of 6.1% falls below analyst expectations which forecast a rise to 9.4%, and a significant one-off loss further impacted profitability. While HURN appears undervalued based on P/E and DCF, concerns about its debt coverage and cash generation create tension with the bullish outlook on margin expansion.
Huron Consulting Group (NASDAQ:HURN) Stock Price Down 13.7% - Should You Sell?
Huron Consulting Group (NASDAQ:HURN) shares dropped 13.7% despite beating Q1 revenue and EPS expectations and reaffirming FY-2026 guidance. The stock's decline is attributed to negative financial signals such as negative operating cash flow, rising liabilities, and recent insider and institutional selling. While analysts maintain a "Moderate Buy" consensus with significant upside potential, investors are urged to consider these financial and selling pressures.
Huron Consulting Group stock hits 52-week low at 115.46 USD
Huron Consulting Group Inc. (HURN) stock has fallen to a 52-week low of $115.46, representing a 20.75% decline over the past year. Despite the recent downturn and significant year-to-date losses, InvestingPro data suggests the stock is undervalued, with the company remaining profitable and management actively repurchasing shares. This comes after the firm reported a strong Q1 2026, surpassing earnings and revenue expectations.
Huron Consulting (NASDAQ: HURN) posts Q1 2026 growth with higher revenue, leverage and buybacks
Huron Consulting Group reported a Q1 2026 revenue increase to $451.8 million, up from $404.1 million year-over-year, driven by growth across its Healthcare, Education, and Commercial segments. Despite a slight dip in net income to $23.2 million (from $24.5 million in Q1 2025), diluted EPS rose slightly to $1.34 due to share repurchases. The company maintained strong capital deployment, repurchasing over 1.1 million shares for $155.5 million and managing an increased debt of $856.0 million while staying within financial covenants.
Huron Consulting Group Inc. 1Q 2026: Revenue $443.71M, EPS $1.34— 10-Q Summary
Huron Consulting Group Inc. reported strong first-quarter 2026 results, with revenue increasing by 12.1% to $443.71 million and diluted EPS reaching $1.34. The growth was driven by a 21.3% rise in Consulting & Managed Services revenue, supported by increased demand in Healthcare and Commercial sectors, expanded digital offerings, and strategic acquisitions. Net income, however, slightly declined by 5.3% to $23.25 million compared to the prior-year quarter.
Director John McCartney trims Huron (HURN) stake in 500-share sale
Huron Consulting Group director John McCartney sold 500 shares of common stock on May 1, 2026, for $132.04 per share. This transaction was automatically executed under a pre-arranged Rule 10b5-1 trading plan adopted in August 2024. After the sale, McCartney still directly owns 40,317 Huron shares, indicating that this was a routine portfolio adjustment rather than a significant change in his stake.
Huron Consulting Group (NASDAQ:HURN) Issues Quarterly Earnings Results, Beats Estimates By $0.15 EPS
Huron Consulting Group (NASDAQ:HURN) announced strong Q1 earnings, surpassing analyst estimates by $0.15 EPS with reported earnings of $1.73 and revenue of $451.8 million, up 12.1% year-over-year. The company affirmed its full-year 2026 guidance, driven by growth in its Healthcare, Education, and Commercial segments. Despite positive revenue and EPS beats, concerns were raised regarding negative free cash flow, increased net debt, and leverage, though management anticipates these are seasonal and will normalize by year-end.
Huron (HURN) grows Q1 2026 revenue 12% and reaffirms full-year outlook
Huron Consulting Group (HURN) reported a strong first quarter for 2026, with revenues before reimbursable expenses increasing 12.1% to $443.7 million, driven by growth across Healthcare, Education, and Commercial segments. Despite a slight dip in net income due to a higher tax expense, adjusted EBITDA rose by 21.9% to $50.6 million. The company reaffirmed its full-year 2026 guidance, projecting RBR between $1.78 billion and $1.86 billion, and committed to shareholder returns through significant share repurchases.
Insider Sell: John Mccartney Sells 500 Shares of Huron Consultin
John Mccartney, a Director at Huron Consulting Group Inc (HURN), sold 500 shares of the company on May 1, 2026, reducing his holding to 40,317 shares. This transaction is part of a larger trend of 47 insider sells and no buys over the past year. Despite the insider selling, HURN's stock is considered modestly undervalued with a price-to-GF-Value ratio of 0.89, trading at $132.04 against a GF Value of $148.10.
Huron Consulting Gr Q1 2026 Earnings Call Transcript
Huron Consulting Group Inc. (NASDAQ: HURN) reported a 12% increase in Q1 2026 revenues before reimbursable expenses, driven by growth across healthcare, education, and commercial segments. The company affirmed its 2026 guidance, maintaining expectations for RVR, adjusted EBITDA margin, and adjusted diluted EPS, and emphasized ongoing investment in AI capabilities and disciplined capital allocation. Management remains bullish on AI's potential to contribute significantly to future growth and margin expansion, citing strong pipeline and backlog.
Huron (NASDAQ:HURN) Beats Q1 CY2026 Sales Expectations
Huron Consulting Group (NASDAQ:HURN) surpassed Q1 CY2026 sales and EPS expectations, with revenue up 11.8% year-on-year to $451.8 million and adjusted EPS of $1.73. The company reconfirmed its full-year revenue guidance of $1.82 billion and adjusted EPS guidance of $8.75. Despite strong past revenue and EPS growth, the stock traded up 1.8% after the results, which showed key positives, including an improved operating margin.
Earnings call transcript: Huron Consulting Group Q1 2026 beats expectations
Huron Consulting Group reported a strong Q1 2026, surpassing earnings expectations with an EPS of $1.73 against a forecast of $1.61, and revenue of $443.7 million. Key drivers included robust growth in its Healthcare segment, with overall revenue up 12.1% year-over-year. The company affirmed its 2026 guidance, highlighting a strong pipeline and strategic investments in AI, and remains committed to its long-term growth strategy and shareholder value.
